IL-2

Interleukin-2

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for IL-2, covering 2019-11-29 to 2023-04-03. Get the full timeline:

Most recent: Clinical Trial Update: FT516 and IL2 With Enoblituzumab for Ovarian Cancer [Phase 1]